Boxer Capital Management, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Boxer Capital Management, LLC held in its portfolio 45 assets valued at $456,875,787 (i.e. $456.88M).
The most valuable assets in the portfolio included: TANGO THERAPEUTICS INC ($96.36M), REVOLUTION MEDICINES INC ($31.86M), and KODIAK SCIENCES INC ($31.76M).
The chart below shows the top 10 valuable assets, and the table below shows the top 45 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Boxer Capital Management, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| TANGO THERAPEUTICS INC | 10876219 | 96363300 | COM |
| REVOLUTION MEDICINES INC | 400000 | 31860000 | COM |
| KODIAK SCIENCES INC | 1136000 | 31762560 | COM |
| KYMERA THERAPEUTICS INC | 329100 | 25607271 | COM |
| CELCUITY INC | 225000 | 22441500 | COM |
| ABIVAX SA | 125000 | 16856875 | SPONSORED ADS |
| PTC THERAPEUTICS INC | 200000 | 15192000 | COM |
| TERNS PHARMACEUTICALS INC | 375000 | 15150000 | COM |
| PROTAGONIST THERAPEUTICS INC | 170000 | 14847800 | COM |
| PRAXIS PRECISION MEDICINES I | 46457 | 13692736 | COM NEW |
| UROGEN PHARMA LTD | 500000 | 11710000 | COM |
| CIDARA THERAPEUTICS INC | 53000 | 11707170 | COM NEW |
| PALISADE BIO INC | 4799875 | 11279706 | COM |
| AMYLYX PHARMACEUTICALS INC | 800000 | 9664000 | COM |
| SURROZEN INC | 416150 | 9404990 | COM NEW |
| CAPRICOR THERAPEUTICS INC | 325000 | 9379500 | COM NEW |
| MIND MEDICINE MINDMED INC | 598500 | 8013915 | COM NEW |
| COGENT BIOSCIENCES INC | 225000 | 7992000 | COM |
| REPLIMUNE GROUP INC | 750000 | 7290000 | COM |
| UNIQURE NV | 290000 | 6939700 | SHS |
| CYTOKINETICS INC | 100000 | 6354000 | COM NEW |
| CYBIN INC | 715000 | 5848700 | COM NEW |
| PRECIGEN INC | 1375000 | 5747500 | COM |
| CONTINEUM THERAPEUTICS INC | 494000 | 5646420 | CL A |
| CRESCENT BIOPHARMA INC. | 453686 | 5380716 | COM |
| APOGEE THERAPEUTICS INC | 70000 | 5283600 | COM |
| STRUCTURE THERAPEUTICS INC | 75000 | 5216250 | SPONSORED ADS |
| AVALO THERAPEUTICS INC | 275000 | 4994000 | COM NEW |
| INOVIO PHARMACEUTICALS INC | 2420122 | 4211012 | COM SHS |
| UPSTREAM BIO INC | 150000 | 4072500 | COM |
| VIR BIOTECHNOLOGY INC | 625000 | 3768750 | COM |
| INVIVYD INC | 1500000 | 3705000 | COM |
| MOONLAKE IMMUNOTHERAPEUTICS | 275000 | 3624500 | CLASS A ORD |
| SAREPTA THERAPEUTICS INC | 150000 | 3228000 | COM |
| PEPGEN INC | 373892 | 2434037 | COM |
| NURIX THERAPEUTICS INC | 100000 | 1897000 | COM |
| KARYOPHARM THERAPEUTICS INC | 252536 | 1858665 | COM NEW |
| SOLID BIOSCIENCES INC | 300000 | 1692000 | COM NEW |
| LB PHARMACEUTICALS INC | 70000 | 1558200 | COM SHS |
| MILESTONE PHARMACEUTICALS IN | 666666 | 1346665 | COM |
| CLENE INC | 199737 | 1172456 | COM NEW |
| KALVISTA PHARMACEUTICALS INC | 20400 | 329460 | COM |
| ZURA BIO LTD | 50000 | 262000 | CLASS A ORD SHS |
| NUVATION BIO INC | 266666 | 88000 | *W EXP 02/10/202 |
| SURROZEN INC | 66666 | 1333 | *W EXP 08/01/203 |